Experimental research for the availability of gene therapy using ORP150, a novel molecular chaperone
使用新型分子伴侣 ORP150 进行基因治疗可用性的实验研究
基本信息
- 批准号:12671522
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Newly synthesized protein and immature proteins are easily aggregated because they ej(pose hydrophobic regions. Many stress conditions, such as heat shock or hypoxia, slow down their folding process and cause accumulation of unfolded/misfolded proteins in the cell. Molecular chaperones, including heat shock'proteins (IISPs), are induced in these conditions, bind to unfolded/misfolded proteins, and help them to be folded or reflolded properly. The protective role of molecular chaperones for the cells under stress has been reported.Expression of angiogenic factors such as vascular endothelial growth factor (VEGF) under conditions of cell stress involves both transcriptionaland translational events, as well as an important role for inducible endoplasmicreticulum (ER) chaperones. Coexpression of VEGF and 150-kDaoxygen-regulated protein (ORP), a novel ER chaperone, in human glioblastomasuggested a link between angiogenesis and ORP150. C6 gliomacells stably transfected with ORP150 antisense … More displayed selectively reduced ORP150 expression. Tumors raised after in culation of immunocompromisedmice with ORP150 antisense C6 glioma transfectants demonstratedan initial phase of growth comparable to wild-type C6 gliomacells which was followed by marked regression within 8 days. Decreaseddensity of platelet/endothelial cell adhesion molecule 1-positive structureswithin the tumor bed was consistent with reduced angiogenesis in C6 gliomas expressing ORP150 antisense, compared with tumors derived from C6 cells overexpressing ORP150 sense or vector controls. In vitro,inhibition of ORP150 expression decreased release of VEGF into culturesupernatants ; in ORP150 antisense transfectants, VEGF accumulatedintracellularly within the ER. These findings demonstrate a critical rolefor the inducible ER chaperone ORP150 in tumor-mediated angiogenesisvia processing of VEGF, and, thus, highlight a new facet of angiogenicmechanisms amenable to therapeutic manipulation in tumors.Heat shock proteins (HSPs)/stress proteins are molecular chaperflnes that are induced by various environmental and physiological stimuli. Evidence of the relations between the expression of HSPs and the regulation of cell growth or transformation has accumulated. The 150-kDa oxygen-regulated protein (ORP150), a new member of lisp family, functions as a molecular chaperone in the endoplasmic reticulum. We have examined whether transduced antisense ORP150 cDNA reduces tumorigenicity and angiogenicity. Relations between these stress proteins and cancer and possibilities for anticancer gene therapy are described. Less
新合成的蛋白质和未成熟的蛋白质容易聚集,因为它们形成疏水区域。许多应激条件,如热休克或缺氧,减缓其折叠过程,并导致未折叠/错误折叠蛋白在细胞中积累。分子伴侣,包括热休克蛋白(IISP),在这些条件下诱导,结合未折叠/错误折叠的蛋白质,并帮助它们正确折叠或重新折叠。分子伴侣对应激状态下细胞的保护作用已有报道,在细胞应激条件下,血管生成因子如血管内皮生长因子(VEGF)的表达涉及转录和翻译事件,诱导型内质网(ER)分子伴侣也发挥重要作用。VEGF和150-kDa氧调节蛋白(ORP),一种新的ER伴侣,在人胶质母细胞瘤中的共表达表明血管生成和ORP 150之间存在联系。稳定转染ORP 150反义核酸的C6胶质瘤细胞 ...更多信息 显示选择性降低的ORP 150表达。用ORP 150反义C6神经胶质瘤转染子培养免疫功能低下的小鼠后,肿瘤生长的初始阶段与野生型C6神经胶质瘤细胞相当,随后在8天内明显消退。与过表达ORP 150正义或载体对照的C6细胞相比,在表达ORP 150反义的C6胶质瘤中,肿瘤床内血小板/内皮细胞粘附分子1阳性结构的密度降低与血管生成减少一致。在体外,抑制ORP 150表达减少了VEGF释放到培养上清液中;在ORP 150反义转染子中,VEGF在ER内细胞内聚集。这些研究结果表明,诱导型ER伴侣蛋白ORP 150在肿瘤介导的血管生成中通过加工VEGF发挥关键作用,因此,突出了肿瘤血管生成机制的一个新方面,适合于治疗操作。热休克蛋白的表达与细胞生长或转化的调节之间的关系的证据已经积累。150-kDa氧调节蛋白(ORP 150)是lisp家族的新成员,在内质网中起分子伴侣的作用。我们已经检查了转导的反义ORP 150 cDNA是否降低致瘤性和血管生成性。这些应激蛋白和癌症之间的关系和抗癌基因治疗的可能性进行了描述。少
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kitao Y., Ozawa K., Miyazaki M., Kobayashi T., Yanagi H., Okabe M., Ikawa M., Yamashima T., Tohyama M., Stern D., Hori O., and Ogawa S.: "Expression of 150 kDa Oxygen Regulated Protein (ORP150), a Molecular Chaperone in the Endoplasmic Reticulum, Rescues
Kitao Y.、小泽 K.、宫崎 M.、小林 T.、柳 H.、冈部 M.、井川 M.、山岛 T.、远山 M.、斯特恩 D.、堀 O. 和小川 S.:“
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tamatani 他: "ORP150 protects against hypoxia/ischemia-induced neuronal death"Nature Med.. 7. 317-323 (2001)
Tamatani 等人:“ORP150 可以防止缺氧/缺血引起的神经元死亡”Nature Med.. 7. 317-323 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Miyagi他: "Antitumor Effect of Reduction of 150-kDa Oxygen-Regulated Protein Expression in Human Prostate Cancer Cells"Mol. Urol.. 5. 79-80 (2001)
Miyagi 等人:“人前列腺癌细胞中 150-kDa 氧调节蛋白表达减少的抗肿瘤作用”Mol Urol.. 5. 79-80 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ozawa K, Tsukamoto Y, Hori O, Kitao Y, Yanagi Stern D, and Ogawa S.: "Regulation of tumor angiogeensis by ORP150, an inducible endoplasmic reticulum chaperone."Can. Res.. 61. 4206-4213 (2001)
Ozawa K、Tsukamoto Y、Hori O、Kitao Y、Yanagi Stern D 和 Okawa S.:“ORP150(一种诱导型内质网伴侣)对肿瘤血管生成的调节”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsukamoto 他: "Expression of a novel RNA splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation"Am. J. Pathol. 158. 1685-1694 (2001)
Tsukamoto 等人:“新型 RNA 剪接因子 RA301/Tra2beta 在血管病变中的表达及其在平滑肌细胞增殖中的作用”Am. J. Pathol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OGAWA Satoshi其他文献
Study on Evaluation Method of Slipperiness for Pets, Fundamental Study on Evaluation Method of Slipperiness
宠物防滑性评价方法研究、防滑性评价方法基础研究
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
YOKOYAMA Yutaka;OGAWA Satoshi;YOKOI Takeshi;ONO Hidenori - 通讯作者:
ONO Hidenori
The Adoption of the Latin American Rice Production System through the Implementation of Advanced Field Management Practices: An Evaluation of Technology Adoption Patterns and the Impact on Yield in Colombia
通过实施先进田间管理实践采用拉丁美洲水稻生产系统:技术采用模式及其对哥伦比亚产量影响的评估
- DOI:
10.5109/2558911 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
ALWARRITZI Widya;NANSEKI Teruaki;OGAWA Satoshi;LY Nguyen Thi;CHOMEI Yosuke;BECERRA Nilson Alfonso Ibarra;GALVIS Ricardo Andres Sanchez;GARC?A Myriam Patricia Guzm?n;VALBUENA Jose Levis Baron - 通讯作者:
VALBUENA Jose Levis Baron
OGAWA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OGAWA Satoshi', 18)}}的其他基金
Nano-interspace Modification of Organic Electronic Devices by Charge Transfer Type Self-assembled Monolayers
电荷转移型自组装单分子层对有机电子器件的纳米间隙修饰
- 批准号:
26410033 - 财政年份:2014
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Control of Nano Interspace of Organic Electronic Devices by Charge Transfer Type Self-assembled Monolayers
电荷转移型自组装单分子层控制有机电子器件纳米间隙
- 批准号:
23550038 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of Organic-Oraganometallic Hybrid Molecules with Mixed-valence Redox Activity
具有混合价氧化还原活性的有机-有机金属杂化分子的设计
- 批准号:
18550027 - 财政年份:2006
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of Multi-center Multi-step Multi-redox Organic and Metallic Hybrid Molecules
多中心多步多氧化还原有机金属杂化分子的设计
- 批准号:
15550023 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rescue of Neuronal Cell Death by ER-stress protein overexpression
通过 ER 应激蛋白过度表达拯救神经元细胞死亡
- 批准号:
15200028 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ESTABLISHMENT OF THE HEART FAILURE THERAPY USING REGENERATED CARDIOMYOCYTE FROM BONE MARROW
建立利用骨髓再生心肌细胞治疗心力衰竭的方法
- 批准号:
12307016 - 财政年份:2000
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Visualization and regulation of ischemia-induced stress response in brain.
大脑缺血引起的应激反应的可视化和调节。
- 批准号:
10480215 - 财政年份:1998
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Morphological, Electrophysiological and Molecular Analysis of the Cardiomyocytes Defferentiated From Bone Marrow Mesenchymal Stem Cells
骨髓间充质干细胞分化心肌细胞的形态学、电生理学和分子分析
- 批准号:
10470170 - 财政年份:1998
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of coronary circulation or pulmonary circulation in the setting of simulated space environments.
在模拟空间环境中调节冠脉循环或肺循环。
- 批准号:
05454276 - 财政年份:1993
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
The effects of the unfolded protein response on medulloblastoma
未折叠蛋白反应对髓母细胞瘤的影响
- 批准号:
8712569 - 财政年份:2012
- 资助金额:
$ 2.05万 - 项目类别:
The effects of the unfolded protein response on medulloblastoma
未折叠蛋白反应对髓母细胞瘤的影响
- 批准号:
8540460 - 财政年份:2012
- 资助金额:
$ 2.05万 - 项目类别:
The effects of the unfolded protein response on medulloblastoma
未折叠蛋白反应对髓母细胞瘤的影响
- 批准号:
8893169 - 财政年份:2012
- 资助金额:
$ 2.05万 - 项目类别:
The effects of the unfolded protein response on medulloblastoma
未折叠蛋白反应对髓母细胞瘤的影响
- 批准号:
8234614 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
UNFOLDED PROTEIN RESPONSE IN DRUG SENSITIVITY AND RESISTANCE
药物敏感性和耐药性中未折叠的蛋白质反应
- 批准号:
8309813 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Pharmacological targeting of the Unfolded Protein Response as an antitumor strate
未折叠蛋白反应的药理学靶向作为抗肿瘤策略
- 批准号:
8294818 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
Pharmacological targeting of the Unfolded Protein Response as an antitumor strate
未折叠蛋白反应的药理学靶向作为抗肿瘤策略
- 批准号:
8193047 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
Pharmacological targeting of the Unfolded Protein Response as an antitumor strate
未折叠蛋白反应的药理学靶向作为抗肿瘤策略
- 批准号:
7644769 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
UNFOLDED PROTEIN RESPONSE IN DRUG SENSITIVITY AND RESISTANCE
药物敏感性和耐药性中未折叠的蛋白质反应
- 批准号:
7313997 - 财政年份:2007
- 资助金额:
$ 2.05万 - 项目类别:
UNFOLDED PROTEIN RESPONSE IN DRUG SENSITIVITY AND RESISTANCE
药物敏感性和耐药性中未折叠的蛋白质反应
- 批准号:
7668518 - 财政年份:
- 资助金额:
$ 2.05万 - 项目类别:














{{item.name}}会员




